Investigation of utility of Hyperbaric Oxygen Treatment (HBOT) for Long-COVID syndrome

Wesley Hyperbaric0 个研究点目标入组 30 人开始时间: 2022年11月8日最近更新: 2022年11月14日

适应症

试验速览

暂无简介。

•18 to 65-year old
•COVID-19 at least 12 weeks prior, +PCR test/ RAT and/or documented clinical symptoms
•Active lifestyle before contracting COVID-19

•Pregnant or lactating women
•Individuals that are unable walk or get in and out of bed by themselves unaided
•Inability to provide written informed consent
•Inability or unwillingness to adhere to 10 HBOT treatment sessions over a 2 to 3 week- time period or to complete questionnaires/testing
•Claustrophobia and inability to enter the hyperbaric chamber for session
•Inability to effectively equalise the middle ear during ambient pressure changes. History of tympanic membrane perforation, head and neck surgery with compromised Eustachian tube function, including tracheostomy, mastoidectomy, middle ear surgical procedures and cochlear implants
•Contraindication to HBOT such as cardiac or respiratory contraindication, bleomycin, spherocytosis or pulmonary fibrosis
•Involved in another clinical trial that does not allow enrolment in other clinical trials

发起方

Wesley Hyperbaric